Sirolimus Market Revenue to close at USD 310.3 MN by 2027
Posted On March 17, 2021
The Global Sirolimus Market is foreseen to grow at a remarkable CAGR of 1.2% during the year 2021-2027 as estimated by the report from Value Market Research wherein the market value is expected to grow to USD 310.3 MN by 2027. Improving healthcare infrastructure and a high increase in organ transplantation rates worldwide are the key driving factors of the immunosuppressive drug sirolimus market. Bolstering research in SRL-based immunosuppressive therapies to meet the demands of the geriatric population will benefit market growth. The growing prevalence of chronic diseases and technological advancements in the organ transplantation systems will boost market share. The rise in disposable income, high living standards, and favorable reimbursement policies propelling organ transplantation demand will be a market booster. Associated side effects like lung toxicity, increased risk of skin cancers, and preference for generic drug variants are some of the barriers that can hurt market growth.
Sirolimus is a novel immunosuppressant drug generally used by kidney transplant recipients to prevent organ rejection. This drug acts on the lymphocytes, dampens down the body’s immune response and its inflammatory response. It has also been approved for treating rare lung disease, lymphangioleiomyomatosis. It is either used alone or with other drugs to provide steroid-free immunosuppression regimens. This chemical compound is used as a coating on coronary stents to prevent restenosis in coronary arteries following balloon angioplasty. Treating lymphatic malformations using sirolimus is feasible. Sirolimus is available as a solution either in multi-dose amber glass bottles or in unit-dose pouches. Sirolimus is mixed with orange juice or water before administration.
The geographical and segmentation study covered in the report "Global Sirolimus Market Report By Application (Organ Transplant Rejection, Lymphangioleiomyomatosis (LAM), Sirolimus Coated Balloons & Catheter Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2027" helps in understanding the upcoming trends of the market.
On the basis of Application the market is segmented into Organ Transplant Rejection, Lymphangioleiomyomatosis (LAM), Sirolimus Coated Balloons & Catheter Devices. By Distribution Channel the sirolimus market is categorised as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. Geographically the research study provides data on North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions. This section provides the estimates of market by segment, thus providing valuable data to take strategic decisions.
The Report Segments Global Sirolimus Market -
- Organ Transplant Rejection
- Lymphangioleiomyomatosis (LAM)
- Sirolimus Coated Balloons & Catheter Devices
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- The Asia Pacific
- Latin America
- The Middle East and Africa
Players Profiled In the Report:
Biocon, Pfizer, Inc, Concept Medical, Stentys SA, Dr. Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd, Intas Pharmaceuticals Ltd, T Concord Biotech, and Zydus Cadila.
Download the FREE SAMPLE of Global Sirolimus Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]